Evidence map›Paper›PMID 40883491›Full record

ArticleNature chemical biology2025

ALFA nanobody-guided endogenous labeling.

Zhe Wang, Fang Hu, Fudong Xue, Wenting He, Lin Yuan, Pingyong Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Programmable nanobody circuits for cell selection.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhe WangKey Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Fang HuKey Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Fudong XueKey Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Wenting HeKey Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Lin YuanKey Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. yuanlin@ibp.ac.cn.ORCID http://orcid.org/0000-0003-1197-8867
Pingyong XuKey Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. pyxu@ibp.ac.cn.ORCID http://orcid.org/0000-0002-8779-6931

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21927813National Natural Science Foundation of China (National Science Foundation of China) 31970704National Natural Science Foundation of China (National Science Foundation of China) 32227802National Natural Science Foundation of China (National Science Foundation of China) 92254306National Natural Science Foundation of China (National Science Foundation of China) T2394513
6 · The paper itself

Abstract

Small peptide tags offer advantages as their compact size reduces target protein interference, making them valuable for labeling endogenous proteins. However, the lack of inherent fluorescence poses challenges for post-genome knockin monoclonal clone screening. Here we report an adaptable approach leveraging antigen-stabilizing fluorescent protein-fused nanobodies (Nbs) to selectively illuminate cells with successful ALFA tag knockins, streamlining high-throughput cell screening using fluorescence-activated cell sorting. Through targeted mutations and screening of ALFA Nbs (NbALFA), the fluorescently labeled Nb can be selectively degraded in the absence of the ALFA peptide. Conversely, successful insertion of the ALFA peptide into the genome results in a substantial increase in the fluorescence intensity of the Nb. This technique, termed ALFA Nb-guided endogenous labeling (ANGEL), enables a wide array of versatile applications within the native cellular environment. These applications include precise protein labeling and signal amplification through the tandem arrangement of ALFA tags, dynamic monitoring of protein behavior, initiation of protein degradation processes and analysis of protein interactome.

Indexed as

Single-Domain AntibodiesStaining and LabelingAnimalsFlow CytometryHEK293 CellsHumansSingle-Domain Antibodies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.